Compare Mutual Funds
Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | |||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 10/11 | |||
Category | Equity, Sector - Healthcare | |||
Fund Age | 14 Years | |||
Fund AUM | ₹9166 Cr | |||
Min Investment |
| |||
Expense Ratio | 1% | |||
Exit Load | 1% | |||
Benchmark Index | BSE Healthcare TR INR |
No of Holdings | 40 | |||
Top 5 Holdings |
| |||
No of Sectors | 1 | |||
Top 3 Sectors | Health (100%) | |||
Equity % | 97.3% | |||
Debt % | - | |||
P/E | 37.98 | |||
P/B | 5.6 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 8.42% | |||
3-Month Return | 2.43% | |||
6-Month Return | 9.74% | |||
1-Year Return | 16.22% | |||
3-Year Return | 18.73% | |||
5-Year Return | 15.45% |
Sharpe | 0.83 | |||
Alpha | -2.19 | |||
Beta | 0.89 | |||
Standard Deviation | 14.87 | |||
Information Ratio | -1.14 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Amber Singhania, Sailesh Raj Bhan, Kinjal Desai |
Most Popular Comparisons
